
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F39205000031780374D5D5.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="jctr" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC4195965/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195965/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Cardiovascular and Thoracic Research" /><meta name="citation_title" content="Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients" /><meta name="citation_author" content="Alexander E. Berezin" /><meta name="citation_author_institution" content="1State Medical University, Internal Medicine Department, Zaporozhye, Ukraine" /><meta name="citation_author" content="Alexander A. Kremzer" /><meta name="citation_author_institution" content="2State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine" /><meta name="citation_author" content="Tatyana A. Samura" /><meta name="citation_author_institution" content="2State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine" /><meta name="citation_author" content="Tatyana A. Berezina" /><meta name="citation_author_institution" content="3Privat Medical center &#x0201c;Vitacenter&#x0201d;, Zaporozhye, Ukraine" /><meta name="citation_author" content="Yulia V. Martovitskaya" /><meta name="citation_author_institution" content="4State Medical University, Pathology Department, Zaporozhye, Ukraine" /><meta name="citation_publication_date" content="2014" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="6" /><meta name="citation_firstpage" content="153" /><meta name="citation_doi" content="10.15171/jcvtr.2014.004" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4195965/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC4195965/" /><meta name="citation_pmid" content="25320662" /><meta name="DC.Title" content="Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Tabriz University of Medical Sciences" /><meta name="DC.Contributor" content="Alexander E. Berezin" /><meta name="DC.Contributor" content="Alexander A. Kremzer" /><meta name="DC.Contributor" content="Tatyana A. Samura" /><meta name="DC.Contributor" content="Tatyana A. Berezina" /><meta name="DC.Contributor" content="Yulia V. Martovitskaya" /><meta name="DC.Date" content="2014" /><meta name="DC.Identifier" content="10.15171/jcvtr.2014.004" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients" /><meta property="og:type" content="article" /><meta property="og:description" content="&#10;Introduction: Serum uric acid (SUA) is considered a marker for natural progression of chronic heart failure (CHF) mediated cardiovascular remodelling. CHF associates with declining of circulating mononuclear progenitor cells (MPCs). The objective of ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195965/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4195965/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2184/">J Cardiovasc Thorac Res</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/243929/">v.6(3); 2014</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC4195965
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC4195965/pdf/JCVTR-6-153.pdf" class="int-view">PDF (699K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/4195965/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/4195965/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="4195965" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="fvzhfHGp0bJL9KIyTKcL0NzLm67dNte5ljYBfx2hMUUI1vVnTVgcQOsIcGc2wBfw">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F&amp;text=Serum%20Uric%20Acid%20Predicts%20Declining%20of%20Circulating%20Proangiogenic%20Mononuclear%20Progenitor%20Cells%20in%20Chronic%20Heart%20Failure%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195965/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/25320662/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/25320662/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/4195965/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/2184/">J Cardiovasc Thorac Res</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/243929/">v.6(3); 2014</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC4195965
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jctr.gif" alt="Logo of jctr" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://jcvtr.tbzmed.ac.ir/" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Cardiovasc Thorac Res.</span> 2014; 6(3): 153–162. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2014 Sep 30. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.15171%2Fjcvtr.2014.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.15171/jcvtr.2014.004</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4195965</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/25320662">25320662</a></div></div></div><h1 class="content-title">Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berezin%20AE%5BAuthor%5D" class="affpopup" co-rid="_co_idm140095526812368" co-class="co-affbox">Alexander E. Berezin</a>,<sup>
1
,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kremzer%20AA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140095479089424" co-class="co-affbox">Alexander A. Kremzer</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Samura%20TA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140095478323968" co-class="co-affbox">Tatyana A. Samura</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berezina%20TA%5BAuthor%5D" class="affpopup" co-rid="_co_idm140095476737728" co-class="co-affbox">Tatyana A. Berezina</a>,<sup>
3
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Martovitskaya%20YV%5BAuthor%5D" class="affpopup" co-rid="_co_idm140095476735360" co-class="co-affbox">Yulia V. Martovitskaya</a><sup>
4
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140095526812368"><h3 class="no_margin">Alexander E. Berezin</h3><p><sup>1</sup>State Medical University, Internal Medicine Department, Zaporozhye, Ukraine
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berezin%20AE%5BAuthor%5D">Alexander E. Berezin</a></div></div><div id="_co_idm140095479089424"><h3 class="no_margin">Alexander A. Kremzer</h3><p><sup>2</sup>State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Kremzer%20AA%5BAuthor%5D">Alexander A. Kremzer</a></div></div><div id="_co_idm140095478323968"><h3 class="no_margin">Tatyana A. Samura</h3><p><sup>2</sup>State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Samura%20TA%5BAuthor%5D">Tatyana A. Samura</a></div></div><div id="_co_idm140095476737728"><h3 class="no_margin">Tatyana A. Berezina</h3><p><sup>3</sup>Privat Medical center &#x0201c;Vitacenter&#x0201d;, Zaporozhye, Ukraine
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Berezina%20TA%5BAuthor%5D">Tatyana A. Berezina</a></div></div><div id="_co_idm140095476735360"><h3 class="no_margin">Yulia V. Martovitskaya</h3><p><sup>4</sup>State Medical University, Pathology Department, Zaporozhye, Ukraine
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Martovitskaya%20YV%5BAuthor%5D">Yulia V. Martovitskaya</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140095523636768_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140095523636768_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140095523636768_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140095523636768_ai" style="display:none"><div class="fm-affl" id="A01"><sup>1</sup>State Medical University, Internal Medicine Department, Zaporozhye, Ukraine
</div><div class="fm-affl" id="A02"><sup>2</sup>State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine
</div><div class="fm-affl" id="A03"><sup>3</sup>Privat Medical center &#x0201c;Vitacenter&#x0201d;, Zaporozhye, Ukraine
</div><div class="fm-affl" id="A04"><sup>4</sup>State Medical University, Pathology Department, Zaporozhye, Ukraine
</div><div id="COR1"><sup>*</sup><strong>Corresponding author:</strong> Alexander E. Berezin, <a href="mailto:dev@null" data-email="ur.liam@nizereb_rd" class="oemail">ur.liam@nizereb_rd</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm140095523636768_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2014 Mar 4; Accepted 2014 Sep 3.</div></div><div class="permissions half_rhythm hide" id="idm140095523636768_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2014 The Author(s)</div><div class="license half_rhythm">
This is an open access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.o.b.s" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.o.b.stitle">Abstract</h2><!--article-meta--><div><p class="p p-first">
<em>Introduction:</em> Serum uric acid (SUA) is considered a marker for natural progression of chronic heart failure (CHF) mediated cardiovascular remodelling. CHF associates with declining of circulating mononuclear progenitor cells (MPCs). The objective of this study was to evaluate the interrelationship between SUA concentrations and proangiogenic MPCs in ischemic CHF patients.
</p><p>
<em>Methods: </em> The study population was structured retrospectively after determining the coronary artery disease (CAD) by contrast-enhanced spiral computed tomography angiography in 126 subjects with symptomatic ischemic mild-to-severe CHF and 128 CAD subjects without CHF. Baseline biomarkers were measured in all patients. Cox proportional multivariate hazard ratio was calculated for predictors of MPCs declining in both CHF and non-CHF patient population predictors of MPCs declining in CHF subjects were examined in stepwise logistic regression. C-statistics, integrated discrimination indices (IDI) and net-reclassification improvement were utilized for prediction performance analyses.
</p><p>
<em>Results:</em> Cox proportional adjusted hazard ratio analyses for CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs by SUA has shown that the higher quartiles (Q3 and Q4) of SUA compared to the lower quartiles (Q1 and Q2) are associated with increased risks of depletion of both CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs. The addition of Q4 SUA to the ABC model improved the relative IDI by 13.8% for depletion of CD14<sup>+</sup>CD309<sup>+</sup> MPCs and by 14.5% for depletion of CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs.
</p><p class="p p-last">
<em>Conclusion: </em> Circulating levels of proangiogenic MPCs are declined progressively depending on the levels of SUA in the HF subjects with CHF. We suggest that even mild elevations of SUA might be used to predict of relative depletion of proangiogenic MPCs among chronic HF patients.
</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Chronic Heart Failure, Serum Uric Acid, Circulating Mononuclear Progenitor Cells, Predictive Value</span></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p class="p p-first">
Chronic heart failure (CHF) has remained as a potentially fatal complication of any cardiovascular diseases.<sup><a href="#R1" rid="R1" class=" bibr popnode">1</a></sup> Serum uric acid (SUA) has been shown to be an independent predictor of outcome in the general population and in patients with HF, the metabolic syndrome, type-2 diabetes mellitus (T2DM), chronic kidney disease and atherosclerosis.<sup><a href="#R2" rid="R2" class=" bibr popnode">2</a></sup> Although sustained hyperuricemia is considered an independent factor that is adversely associated with a higher mortality, however its causal role is yet to be established in CHF.<sup><a href="#R3" rid="R3" class=" bibr popnode">3</a></sup> Meta-analysis provided by Huang et al suggested that existing hyperuricemia was associated with 65% increases in the risk of suffering from HF (HR 1.65; 1.41&#x02013;1.94) and that for every 1 mg/dL increase in SUA, the odds of developing CHF increased by 19% (HR 1.19; 1.17&#x02013;1.21).<sup><a href="#R4" rid="R4" class=" bibr popnode">4</a></sup> Tamariz et al reported that SUA predicts all-cause mortality in CHF.<sup><a href="#R5" rid="R5" class=" bibr popnode">5</a></sup> There is a controversy in the causal role of hyperuricemia in HF.<sup><a href="#R6" rid="R6" class=" bibr popnode">6</a></sup>
</p><p>
Less is known about the association between SUA levels and circulating mononuclear progenitor cells (MPCs). These cells possess angiopoetic function and are crucial in tissue repair.<sup><a href="#R7" rid="R7" class=" bibr popnode">7</a></sup> It has been shown that MPCs are recruited by the proinflammatory cytokines that are produced in patients with CHF.<sup><a href="#R8" rid="R8" class=" bibr popnode">8</a>,<a href="#R9" rid="R9" class=" bibr popnode">9</a></sup> Substantially, many studies have demonstrated that circulating MPCs are declined progressively depending severity of CHF.<sup><a href="#R10" rid="R10" class=" bibr popnode">10</a>-<a href="#R12" rid="R12" class=" bibr popnode">12</a></sup> We postulate that depletion of MPCs in the peripheral blood may link SUA to the inflammatory responses and the clinical outcome of patients with CHF. Therefore, CD34<sup>+</sup> MPC count is not associated with cardiovascular remodelling or clinical outcome in CHF patients.<sup><a href="#R12" rid="R12" class=" bibr popnode">12</a>,<a href="#R13" rid="R13" class=" bibr popnode">13</a></sup>
</p><p class="p p-last">
Recent evidence suggests that the number of circulating proangiogenic CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie<sup>+2</sup> MPCs is decreased in patients with compensated CHF, however, a linear relation between the number of these cells and SUA level has yet to be investigated.<sup><a href="#R14" rid="R14" class=" bibr popnode">14</a></sup> the objective of this study was to evaluate such a relationship between SUA and the number of proangiogenic population of MPCs in the peripheral blood of the patients with ischemic CHF.
</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and methods</h2><div id="s2-1" class="sec sec-first"><h3 id="s2-1title">
Study population
</h3><p class="p p-first-last">
The study population was structured retrospectively after determining the coronary artery disease (CAD) by contrast-enhanced spiral computed tomography angiography in 126 subjects with symptomatic ischemic mild-to-severe CHF and 128 CAD subjects without HF. CHF was diagnosed according to the current clinical guidelines.<sup><a href="#R15" rid="R15" class=" bibr popnode">15</a></sup> All patients consented to voluntary participation in the study. Patients were excluded if they had a recent (within 3 months prior to study enrolment) myocardial infarction (MI) with or without Q-wave. Additional exclusion criteria included severe kidney disease with serum creatinine &#x0003e;440 &#x003bc;mol/L or estimated glomerular filtration rate (calculated using MDRD-6 formula<sup><a href="#R16" rid="R16" class=" bibr popnode">16</a></sup> ) &#x0003c;35 ml/min/m<sup>2</sup> ;liver diseases that may affect clinical outcomes; malignancy; brain injury within 3 months prior to study enrolment; pulmonary edema; tachyarrhythmias; valvular heart disease; thyrotoxicosis; ischemic stroke; intracranial haemorrhage; acute infections; surgery; trauma; inflammation within a previous month; neoplasm; pregnancy; implanted pacemaker, and patient&#x02019;s refusal to participate in the study.
</p></div><div id="s2-2" class="sec"><h3 id="s2-2title">
Investigation of coronary arteries
</h3><p class="p p-first-last">
Multiplex spiral computed tomographic angiography was carried out to verify the ischemic origin of CHF for all patients prior to their inclusion in the study. When atherosclerotic lesions of the coronary arteries were verified, patients were subjected to conventional angiographic examination provided indications for revascularization were available. Diagnosis of CAD was made only by angiographic exams carried out within 6 months of the study. The coronary artery wall structure was measured while patients were holding their respiration. All measurements were obtained by means of contrast spiral computed tomographic angiography on Somatom Volum Zoom<sup>&#x000ae;</sup> scanner (Siemens, Erlangen, Germany) with two detector rows.<sup><a href="#R17" rid="R17" class=" bibr popnode">17</a></sup> After preliminary native scanning, non-ionic contrast Omnipak (Amersham Health, Ireland) was administered for the optimal image of the coronary arteries. To reconstruct the image, 0.6-mm-width axial tomographic slices were used.
</p></div><div id="s2-3" class="sec"><h3 id="s2-3title">
Echocardiographic examination
</h3><p class="p p-first-last">
A two-dimensional transthoracic echocardiography was performed for all patients using Acuson<sup>&#x000ae;</sup> (Siemens, Germany) system with a 5 &#x0041c;Hz transducer. Routine B-mode images and Doppler measurements were obtained both at the bedside and by post processing. Left ventricular end-diastolic and end-systolic volumes were measured by modified Simpson&#x02019;s method. Left ventricular ejection fraction (LVEF) was assessed in compliance with the requirements of American Society of Echocardiography.<sup><a href="#R18" rid="R18" class=" bibr popnode">18</a></sup> Tissue Doppler echocardiography was carried out in 4-, 3- and 2-chamber projections in each of 16 segments of the left ventricle and in 4 spots of the mitral annulus: at the base of posterior septal, lateral, inferior, and anterior left ventricular walls.<sup><a href="#R18" rid="R18" class=" bibr popnode">18</a></sup> Peak systolic (Sm), early diastolic (Em), and late diastolic (&#x00410;m) myocardial velocities were measured in the mitral annulus area, followed by calculating velocity of early diastolic left ventricular filling (E) to &#x00410;m (&#x00415;/&#x00410;m) ratio and to Em (&#x00415;/Em) ratio.<sup><a href="#R19" rid="R19" class=" bibr popnode">19</a></sup>
</p></div><div id="s2-4" class="sec"><h3 id="s2-4title">
Blood Sampling and Biochemical Measurements
</h3><p class="p p-first-last">
Fasting venous blood samples were collected into silicone test tubes. They were centrifuged upon cooling at 6,000 rpm 430 g for 3 minutes. Then, plasma was refrigerated immediately and stored at a temperature no higher than -35 <sup>&#x000ba;</sup>&#x00421; until they were analysed. Samples were processed according to the recommendations of the manufacturer of the analytical technique. SUA level was measured by enzymatic methods using a chemical analyzer Beckman (Synchron LX20, city, state). Analytical range average for SUA was 0.5-82 mmol/L. N-terminal pro-brain natriuretic peptide (NT-pro-BNP) was measured by immune-electro-chemiluminescence method using sets by R&#x00026;D Systems (city, state, USA) on Elecsys 1010 analyzer (Roche, Mannheim, Germany). Calibration of the assay was performed according to the manufacturer&#x02019;s recommendations and values were normalized to a standard curve. Concentrations of total cholesterol (TC) and high-density lipoprotein (HDL) cholesterol were determined with Dimension Clinical Chemistry System<sup>&#x000ae;</sup> (Dade Behring Inc, Newark, NJ). Low-density lipoprotein (LDL) cholesterol was calculated using Friedewald formula.<sup><a href="#R20" rid="R20" class=" bibr popnode">20</a></sup>
</p></div><div id="s2-5" class="sec"><h3 id="s2-5title">
Flow Cytometry and cytologic experiments
</h3><p class="p p-first-last">
High-Definition Fluorescence Activated Cell Sorter (HD-FACS) was used to detect circulating cells subsets depending on the expression of CD45, CD34, CD14, Tie-2, and VEGFR2, as previously described.<sup><a href="#R21" rid="R21" class=" bibr popnode">21</a></sup> Accordingly, the cells in question were labeled on the basis of their forward scatter characteristic (FSC) and side scatter characteristic (SSC) profiles. The cells were directly stained and analysed for the phenotypic expression of surface proteins using anti-human monoclonal antibodies, including anti-CD45 FITC (BD Biosciences, USA), anti-CD34 FITC (BD Biosciences, USA), anti-VEGFR-2 known as anti-CD309 FITC (BD Biosciences, USA), anti-Tie2 (BD Biosciences, USA) and anti-CD14 (BD Biosciences, USA) (For all cases labelling up to 2 &#x000d7; 10<sup>9</sup> cells). The fluorescence minus one technique was used to provide negative controls and establish positive stain boundaries. After lysis of erythrocytes with Utilize<sup>&#x000ae;</sup> wash solution, the samples were centrifuged at 200 g for 15 min; then they were washed twice with phosphate buffer solution and fixed immediately. Double- or triple-positive events were determined using Boolean principles (&#x02018;and&#x02019;, &#x02018;not&#x02019;, &#x02018;or&#x02019;, etc.). Circulating endothelial progenitor cells (EPCs) are defined as CD34/VEGFR2 positive cells in lack of CD45 expression. 500,000 events were analyzed from each tube. For CD14<sup>+</sup> populations, co-expression with Tie-2- and/or VEGFR-2- was determined using quadrant analysis. Standardized cell counts were presented as a percentage of total white blood cells count, which were identified as the total number of all CD45<sup>+</sup> cells.
</p></div><div id="s2-6" class="sec sec-last"><h3 id="s2-6title">
Statistical Analysis
</h3><p class="p p-first-last">
Statistical analysis of the results obtained was carried out in SPSS system for Windows, Version 20 (SPSS Inc, Chicago, IL, USA). The data were presented as mean and the standard errors of means or 95% confidence interval (CI); median and interquartile range (IQR). To compare categorical variables between groups, Chi squaretest (&#x003c7;<sup>2</sup> ) and Fisher&#x02019;s exact test were used. The circulating NT-pro-BNP and SUA level in the blood failed to have a normal distribution, while distribution of the TG (triglycerides) and cholesterol fractions had a normal character (estimated by means of Kolmogorov-Smirnov test) and was not subjected to any mathematical transformation. Kruskal&#x02013;Wallis test was used for difference in medians across quartiles of SUA. For further analysis concentrations of SUA in CHF patients were distributed by quartiles: QI (less 22.33 mmol/L), QII (23.2 to 31/10 mmol/L), QIII (32.0 to 39.0 mmol/L), QIV (40.00 to 49.60 mmol/L). QI=20.11 (19.0622.33) mmol/L; QII=27.53 (23.2; 31.10) mmol/L; QIII=35.80 (32.0; 39.0) mmol/L; and QIV=44.9 (40.00; 49.60) mmol/L. The factors, which could be associated potentially with MPCs declining, were determined by univariate and then multivariate regression analysis. Cox proportional multivariate odds ratio (OR) and 95% CI were calculated for predictors of MPCs declining in CHF and non-CHF patient population. Receiver operating characteristic (ROC) curves was configured to establish cut-off points of SUA level that optimally predicted decreased MPCs. Predictors of MPCs declining were examined in stepwise logistic regression with subjects with complications at the time of enrollment excluded from analyses. C-statistics, integrated discrimination indices (IDI) and net-reclassification improvement (NRI) were utilized for prediction performance analyses in CHF patients. A calculated probability of less than 0.05 was considered significant.
</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3-1" class="sec sec-first"><h3 id="s3-1title">
General characteristics of study patient population
</h3><p class="p p-first">
<a href="/pmc/articles/PMC4195965/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a> shows a general characteristic of the patients included in the study. There were no substantial age and gender differences between the groups. The functional class of the patients with CHF were almost equally distributed from NYHA class I through NYHA class III (30.2%; 38.1%; and 31.7% respectively). Co-morbid conditions were dyslipidaemia (44.4%), hypertension (66.7%) and T2DM (36.5%). Additionally, CHF and non-CHF patients had similar cardiovascular risk, biochemical biomarkers and hemodynamic characteristics. As expected, circulating NT-pro-BNP was higher in CHF patients when compared with CHF-free CAD subjects. SUA levels for subjects with CHF (31.0; 22.8-41.9 mmol/L) were similar to those without CHF (28.5; 20.2-37.6 mmol/L, P=0.26).
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>
Table 1
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
General characteristics of study patient population
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="2" colspan="1">
</td><td rowspan="2" colspan="1">
<strong>Patients without CHF</strong>
<br />
<strong>(n=128)</strong>
</td><td colspan="5" align="center" rowspan="1">
<strong>Patients with CHF (n=126)</strong>
</td><td rowspan="2" colspan="1">
<strong>P value</strong>
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Entire cohort patients with CHF</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile I (19.06-22.33 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile II (23.2-31.10 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile III (32.0-39.0 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile IV (40.00 - 49.60 mmol/L</strong>
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Age, years</td><td rowspan="1" colspan="1">57.80&#x000b1;6.38</td><td rowspan="1" colspan="1">58.34&#x000b1;9.60</td><td rowspan="1" colspan="1">57.70&#x000b1;6.10</td><td rowspan="1" colspan="1">57.40&#x000b1;6.76</td><td rowspan="1" colspan="1">60.30&#x000b1;4.20</td><td rowspan="1" colspan="1">62.60&#x000b1;6.22</td><td rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">Male, n (%)</td><td rowspan="1" colspan="1">72 (56.3%)</td><td rowspan="1" colspan="1">74 (58.7%)</td><td rowspan="1" colspan="1">17 (44.7%)</td><td rowspan="1" colspan="1">21 (65.6%)</td><td rowspan="1" colspan="1">18 (66.7%)</td><td rowspan="1" colspan="1">18 (62.0%)</td><td rowspan="1" colspan="1">0.28</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Framingham General Cardiovascular Risk, %</td><td rowspan="1" colspan="1">22 (16-26)</td><td rowspan="1" colspan="1">23 (16 - 27)</td><td rowspan="1" colspan="1">22 (15 - 26)</td><td rowspan="1" colspan="1">24 (16-30)</td><td rowspan="1" colspan="1">23 (17-31)</td><td rowspan="1" colspan="1">23 (16-30)</td><td rowspan="1" colspan="1">0.75</td></tr><tr><td rowspan="1" colspan="1">NYHA class I, n (%)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">38 (30.2%)</td><td rowspan="1" colspan="1">11 (29.0%)</td><td rowspan="1" colspan="1">9 (28.1%)</td><td rowspan="1" colspan="1">8 (29.6%)</td><td rowspan="1" colspan="1">10 (34.4%)</td><td rowspan="1" colspan="1">0.42</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">NYHA class II, n (%)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">48 (38.1%)</td><td rowspan="1" colspan="1">14 (36.8%)</td><td rowspan="1" colspan="1">12 (37.5%)</td><td rowspan="1" colspan="1">10 (37.0%)</td><td rowspan="1" colspan="1">12 (41.4%)</td><td rowspan="1" colspan="1">0.44</td></tr><tr><td rowspan="1" colspan="1">NYHA class III, n (%)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">40 (31.7%)</td><td rowspan="1" colspan="1">13 (34.2%)</td><td rowspan="1" colspan="1">11 (34.4%)</td><td rowspan="1" colspan="1">9 (33.3%)</td><td rowspan="1" colspan="1">7 (24.1%)</td><td rowspan="1" colspan="1">0.48</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Hypertension, n (%)</td><td rowspan="1" colspan="1">81 (63.3%)</td><td rowspan="1" colspan="1">84 (66.7%)</td><td rowspan="1" colspan="1">25 (65.8%)</td><td rowspan="1" colspan="1">22 (68.8%)</td><td rowspan="1" colspan="1">18 (66.7%)</td><td rowspan="1" colspan="1">19 (65.5%)</td><td rowspan="1" colspan="1">0.86</td></tr><tr><td rowspan="1" colspan="1">Dyslipidaemia, n (%)</td><td rowspan="1" colspan="1">52 (40.6%)</td><td rowspan="1" colspan="1">56 (44.4%)</td><td rowspan="1" colspan="1">17 (44.7%)</td><td rowspan="1" colspan="1">15 (46.9%)</td><td rowspan="1" colspan="1">12 (44.4%)</td><td rowspan="1" colspan="1">12 (41.3%)</td><td rowspan="1" colspan="1">0.79</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">T2DM, n (%)</td><td rowspan="1" colspan="1">48 (37.5%)</td><td rowspan="1" colspan="1">46 (36.5%)</td><td rowspan="1" colspan="1">14 (36.8%)</td><td rowspan="1" colspan="1">12 (37.5%)</td><td rowspan="1" colspan="1">10 (37.0%)</td><td rowspan="1" colspan="1">10 (34.5%)</td><td rowspan="1" colspan="1">0.80</td></tr><tr><td rowspan="1" colspan="1">Premature CAD, n (%)</td><td rowspan="1" colspan="1">14 (10.9%)</td><td rowspan="1" colspan="1">12 (9.5%)</td><td rowspan="1" colspan="1">3 (7.9%)</td><td rowspan="1" colspan="1">3 (9.3%)</td><td rowspan="1" colspan="1">2 (7.40%)</td><td rowspan="1" colspan="1">4 (13.9%)</td><td rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Smoking, n (%)</td><td rowspan="1" colspan="1">28 (21.8%)</td><td rowspan="1" colspan="1">26 (20.6%)</td><td rowspan="1" colspan="1">8 (21.0%)</td><td rowspan="1" colspan="1">6 (18.8%)</td><td rowspan="1" colspan="1">5 (18.5%)</td><td rowspan="1" colspan="1">7 (24.1%)</td><td rowspan="1" colspan="1">0.42</td></tr><tr><td rowspan="1" colspan="1">
BMI, kg/m<sup>2</sup>
</td><td rowspan="1" colspan="1">23.6 (95% CI 21.8&#x02013;27.6)</td><td rowspan="1" colspan="1">
24.1 (95% CI<br /> 21.6 &#x02013; 28.7)
</td><td rowspan="1" colspan="1">
23.3 (95% <br />CI 20.1&#x02013;25.1)
</td><td rowspan="1" colspan="1">25.0 (95% CI 20.8&#x02013;27.2)</td><td rowspan="1" colspan="1">24.6 (95% CI 19.4&#x02013;25.9)</td><td rowspan="1" colspan="1">25.2 (95% CI 19.5&#x02013;25.5)</td><td rowspan="1" colspan="1">0.58</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Mean systolic BP, mm Hg</td><td rowspan="1" colspan="1">131.20&#x000b1;4.66</td><td rowspan="1" colspan="1">130.90&#x000b1;8.41</td><td rowspan="1" colspan="1">127.30&#x000b1;5.98</td><td rowspan="1" colspan="1">133.80&#x000b1;6.12</td><td rowspan="1" colspan="1">129.20&#x000b1;6.34</td><td rowspan="1" colspan="1">128.10&#x000b1;4.93</td><td rowspan="1" colspan="1">0.44</td></tr><tr><td rowspan="1" colspan="1">Mean diastolic BP, mm Hg</td><td rowspan="1" colspan="1">76.10&#x000b1;3.97</td><td rowspan="1" colspan="1">77.24&#x000b1;4.22</td><td rowspan="1" colspan="1">76.85&#x000b1;3.15</td><td rowspan="1" colspan="1">77.17&#x000b1;3.21</td><td rowspan="1" colspan="1">77.10&#x000b1;3.11</td><td rowspan="1" colspan="1">77.70&#x000b1;2.95</td><td rowspan="1" colspan="1">0.42</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Heart rate, beat per min</td><td rowspan="1" colspan="1">69.42&#x000b1;3.88</td><td rowspan="1" colspan="1">70.52&#x000b1;3.34</td><td rowspan="1" colspan="1">68.56&#x000b1;5.11</td><td rowspan="1" colspan="1">70.44&#x000b1;5.68</td><td rowspan="1" colspan="1">71.36&#x000b1;4.66</td><td rowspan="1" colspan="1">70.16&#x000b1;5.12</td><td rowspan="1" colspan="1">0.52</td></tr><tr><td rowspan="1" colspan="1">LV EF, %</td><td rowspan="1" colspan="1">50.40&#x000b1;2.25</td><td rowspan="1" colspan="1">43.80&#x000b1;0.77</td><td rowspan="1" colspan="1">44.10&#x000b1;0.94</td><td rowspan="1" colspan="1">43.50&#x000b1;0.97</td><td rowspan="1" colspan="1">43.60&#x000b1;0.79</td><td rowspan="1" colspan="1">43.10&#x000b1;0.85</td><td rowspan="1" colspan="1">0.28</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">&#x00415;/&#x00410;m, U</td><td rowspan="1" colspan="1">15.1&#x000b1;1.13</td><td rowspan="1" colspan="1">16.6&#x000b1;0.94</td><td rowspan="1" colspan="1">16.3&#x000b1;0.82</td><td rowspan="1" colspan="1">16.5&#x000b1;0.76</td><td rowspan="1" colspan="1">16.5&#x000b1;0.82</td><td rowspan="1" colspan="1">17.1&#x000b1;0.72</td><td rowspan="1" colspan="1">0.48</td></tr><tr><td rowspan="1" colspan="1">&#x00415;/Em, U</td><td rowspan="1" colspan="1">15.4&#x000b1;1.22</td><td rowspan="1" colspan="1">16.6&#x000b1;1.00</td><td rowspan="1" colspan="1">16.2&#x000b1;0.89</td><td rowspan="1" colspan="1">16.6&#x000b1;0.72</td><td rowspan="1" colspan="1">17.2&#x000b1;0.55</td><td rowspan="1" colspan="1">17.0&#x000b1;0.56</td><td rowspan="1" colspan="1">0.46</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
eGFR, mL/min/m<sup>2</sup>
</td><td rowspan="1" colspan="1">
88.5 (95%<br />CI=66.1&#x02013;112.3)
</td><td rowspan="1" colspan="1">
82.3 (95% <br />CI=68.7&#x02013;102.6)
</td><td rowspan="1" colspan="1">
93.5 (95%<br /> CI=88.3&#x02013;100.3)
</td><td rowspan="1" colspan="1">86.1 (95% CI=68.3&#x02013;104.1)</td><td rowspan="1" colspan="1">83.5 (95% CI=68.3&#x02013;112.6)</td><td rowspan="1" colspan="1">76.2 (95% CI=61.1&#x02013;98.3)</td><td rowspan="1" colspan="1">0.045</td></tr><tr><td rowspan="1" colspan="1">HbA1c, %</td><td rowspan="1" colspan="1">6.5 (95% CI=4.3&#x02013;8.7)</td><td rowspan="1" colspan="1">6.8 (95% CI=4.1-9.5)</td><td rowspan="1" colspan="1">6.8 (95% CI=3.9&#x02013;8.9)</td><td rowspan="1" colspan="1">6.9 (95% CI=3.5&#x02013;9.6)</td><td rowspan="1" colspan="1">6.8 (95% CI=3.7&#x02013;8.9)</td><td rowspan="1" colspan="1">6.9 (95% CI=3.8&#x02013;9.2)</td><td rowspan="1" colspan="1">0.86</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Fasting glucose, mmol/L</td><td rowspan="1" colspan="1">5.10 (95% CI=3.5&#x02013;8.3)</td><td rowspan="1" colspan="1">5.20 (95% CI=3.3-9.1)</td><td rowspan="1" colspan="1">5.11 (95% CI=3.2&#x02013;8.5)</td><td rowspan="1" colspan="1">5.28 (95% CI=3.1&#x02013;8.9)</td><td rowspan="1" colspan="1">5.21 (95% CI=3.0&#x02013;9.5)</td><td rowspan="1" colspan="1">5.17 (95% CI=3.2&#x02013;9.0)</td><td rowspan="1" colspan="1">0.87</td></tr><tr><td rowspan="1" colspan="1">Creatinin, &#x003bc;mol/L</td><td rowspan="1" colspan="1">70.6 (95% CI=53.5&#x02013;92.5)</td><td rowspan="1" colspan="1">
72.3 (95% <br />CI=58.7&#x02013;92.6)
</td><td rowspan="1" colspan="1">
70.7 (95%<br /> CI=53.1&#x02013;98.5)
</td><td rowspan="1" colspan="1">71.1 (95% CI=55.7&#x02013;108.2)</td><td rowspan="1" colspan="1">73.7 (95% CI=53.8&#x02013;109.5)</td><td rowspan="1" colspan="1">88.1 (95% CI=63.0&#x02013;134.2)</td><td rowspan="1" colspan="1">0.048</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">TC, mmol/L</td><td rowspan="1" colspan="1">5.3 (95% CI=4.1&#x02013;6.2)</td><td rowspan="1" colspan="1">5.1 (95% CI=3.9-6.1)</td><td rowspan="1" colspan="1">5.0 (95% CI=3.7&#x02013;6.4)</td><td rowspan="1" colspan="1">5.1 (95% CI=3.8&#x02013;6.3)</td><td rowspan="1" colspan="1">5.0 (95% CI=3.9&#x02013;6.0)</td><td rowspan="1" colspan="1">5.0 (95% CI=3.7&#x02013;6.2)</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">HDL cholesterol, mmol/L</td><td rowspan="1" colspan="1">0.95 (95% CI=0.90&#x02013;1.07)</td><td rowspan="1" colspan="1">0.91 (95% CI=0.89-1.12)</td><td rowspan="1" colspan="1">0.95 (95% CI=0.92&#x02013;1.14)</td><td rowspan="1" colspan="1">0.94 (95% CI=0.88&#x02013;1.12)</td><td rowspan="1" colspan="1">0.91 (95% CI=0.86&#x02013;1.13)</td><td rowspan="1" colspan="1">0.90 (95% CI=0.83&#x02013;1.10)</td><td rowspan="1" colspan="1">0.12</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">LDL cholesterol, mmol/L</td><td rowspan="1" colspan="1">3.34 (95% CI=3.20&#x02013;4.64)</td><td rowspan="1" colspan="1">3.23 (95% CI=3.11-4.4)</td><td rowspan="1" colspan="1">2.95 (95% CI=2.84&#x02013;4.6)</td><td rowspan="1" colspan="1">3.15 (95% CI=2.90&#x02013;4.6)</td><td rowspan="1" colspan="1">3.24 (95% CI=3.01&#x02013;4.7)</td><td rowspan="1" colspan="1">3.265 (95% CI=2.98&#x02013;4.64)</td><td rowspan="1" colspan="1">0.64</td></tr><tr><td rowspan="1" colspan="1">NT-pro-BNP, pg/mL</td><td rowspan="1" colspan="1">
243.7 (95% <br />CI=149.8&#x02013;369.5)
</td><td rowspan="1" colspan="1">
1533.6 (95%<br />CI=644.5&#x02013;2560.6)
</td><td rowspan="1" colspan="1">
1263.9 (95%<br /> CI=688.2&#x02013;2120.4)
</td><td rowspan="1" colspan="1">1446.2 (95% CI=612.6&#x02013;2873.5)</td><td rowspan="1" colspan="1">1590.6 (95% CI=622.4&#x02013;2710.2)</td><td rowspan="1" colspan="1">1873.5 (95% CI=711.2&#x02013;2790.4)</td><td rowspan="1" colspan="1">0.22</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095485543488"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.b.c.d.a"><p class="p p-first-last">
Note: CI, confidence interval; T2DM, type 2 diabetes mellitus; eGFR, estimated glomerular filtration ratio; BMI, body mass index; TC, total cholesterol; HbA1c, glycated haemoglobin; LDL, low-density cholesterol; HDL, high-density cholesterol; BP, blood pressure; LVEF, left ventricular ejection fraction; U, unit; Em, early diastolic myocardial velocity; &#x00410;m, late diastolic myocardial velocity; E, peak velocity of early diastolic left ventricular filling.
</p></div></div></div><p>
There was no difference in gender, age and body habitus distribution among SUA quartiles of patients with CHF. However, in patients with no evidence of CHF, SUA concentrations were significantly higher in men (Me= 29.9; 24.5-37.8 mmol/L) than those in women (Me= 23.1; 19.8-30.1 mmol/L, P=0.04). The prevalence of comorbidities; cardiovascular risk, hemodynamic parameters NT-pro-BNP and the NYHA functional class; serum creatinine concentrations and eGFR values; fasting blood glucose concentrations and HbA1c percentages were similar among different quartiles of SUA. The prevalence of premature CAD was higher in 4<sup>th</sup> quartile of SUA when compared to other quartiles (P&#x0003c;0.05). No significant difference was found in anatomic distribution of the stenotic coronary arteries and related atheromatous lesions among the SUA quartiles.
</p><p class="p">
Baseline angiographic and treatment characteristics of study patient population are presented in <a href="/pmc/articles/PMC4195965/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>. Among patients with CHF; 36.5% had single vessel; 33.3% had double vessel and the remaining 20.2% had triple vessel disease. Treatment strategies were according to the current clinical guidelines and were similar in all subgroups ACEI/ARBs and aspirin were given for all patients across SUA quartiles in similar proportions. Compared with the first quartile SUA cohort, patients with QII-IV SUA cohorts had a higher prescribing rate of beta-blockers, anti-aldosterone diuretics (P&#x0003c;0.05), but lower prescribing rate of channel blockers and statins (P&#x0003c;0.05).
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>
Table 2
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
Baseline angiographic and treatment characteristics of study patient population
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Variables</strong>
</td><td rowspan="1" colspan="1">
<strong>Patients without CHF (n=128)</strong>
</td><td rowspan="1" colspan="1">
<strong>Entire cohort patients with CHF (n=126)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile I (19.06-22.33 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile II (23.2 - 31.10 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile III (32.0 - 39.0 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile IV (40.00 - 49.60 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>P</strong>
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Coronary arteries with plaques determined</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">1 vessel, n (%)</td><td rowspan="1" colspan="1">48 (37.5%)</td><td rowspan="1" colspan="1">46 (36.5%)</td><td rowspan="1" colspan="1">12 (31.6%)</td><td rowspan="1" colspan="1">13 (40.6%)</td><td rowspan="1" colspan="1">11 (40.7%)</td><td rowspan="1" colspan="1">10 (34.5%)</td><td rowspan="1" colspan="1">0.66</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">2 vessels, n (%)</td><td rowspan="1" colspan="1">46 (35.9%)</td><td rowspan="1" colspan="1">42 (33.3%)</td><td rowspan="1" colspan="1">13 (34.2%)</td><td rowspan="1" colspan="1">10 (31.3%)</td><td rowspan="1" colspan="1">9 (33.3%)</td><td rowspan="1" colspan="1">10 (34.5%)</td><td rowspan="1" colspan="1">0.72</td></tr><tr><td rowspan="1" colspan="1">3 vessels and more, n (%)</td><td rowspan="1" colspan="1">34 (26.6%)</td><td rowspan="1" colspan="1">38 (30.2%)</td><td rowspan="1" colspan="1">13 (34.2%)</td><td rowspan="1" colspan="1">9 (28.1%)</td><td rowspan="1" colspan="1">7 (25.9%)</td><td rowspan="1" colspan="1">9 (31.0%)</td><td rowspan="1" colspan="1">0.73</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Medications</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">ACEI/ARBs, n (%)</td><td rowspan="1" colspan="1">116 (90.6%)</td><td rowspan="1" colspan="1">126 (100%)</td><td rowspan="1" colspan="1">38 (100%)</td><td rowspan="1" colspan="1">32 (100%)</td><td rowspan="1" colspan="1">27 (100%)</td><td rowspan="1" colspan="1">29 (100%)</td><td rowspan="1" colspan="1">0.52</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Aspirin, n (%)</td><td rowspan="1" colspan="1">101 (78.9%)</td><td rowspan="1" colspan="1">98 (77.8%)</td><td rowspan="1" colspan="1">31 (81.6%)</td><td rowspan="1" colspan="1">25 (65.8%)</td><td rowspan="1" colspan="1">22 (81.5%)</td><td rowspan="1" colspan="1">20 (69.0%)</td><td rowspan="1" colspan="1">0.54</td></tr><tr><td rowspan="1" colspan="1">Other antiagregants, n (%)</td><td rowspan="1" colspan="1">27 (21.1%)</td><td rowspan="1" colspan="1">6 (4.8%)</td><td rowspan="1" colspan="1">2 (5.2%)</td><td rowspan="1" colspan="1">1 (3.1%)</td><td rowspan="1" colspan="1">1 (3.7%)</td><td rowspan="1" colspan="1">2 (6.9%)</td><td rowspan="1" colspan="1">0.86</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Beta-blockers, n (%)</td><td rowspan="1" colspan="1">111 (86.7%)</td><td rowspan="1" colspan="1">104 (82.5%)</td><td rowspan="1" colspan="1">16 (42.1%)</td><td rowspan="1" colspan="1">32 (100%)</td><td rowspan="1" colspan="1">27 (100%)</td><td rowspan="1" colspan="1">29 (100%)</td><td rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td rowspan="1" colspan="1">Ivabradin, n (%)</td><td rowspan="1" colspan="1">36 (28.1%)</td><td rowspan="1" colspan="1">37 (29.4%)</td><td rowspan="1" colspan="1">22 (57.9%)</td><td rowspan="1" colspan="1">12 (37.5%)</td><td rowspan="1" colspan="1">2 (7.4%)</td><td rowspan="1" colspan="1">1 (3.4%)</td><td rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Mineralocorticoid antagonists, n (%)</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">52 (41.3%)</td><td rowspan="1" colspan="1">4 (10.5%)</td><td rowspan="1" colspan="1">19 (59.4%)</td><td rowspan="1" colspan="1">14 (51.9%)</td><td rowspan="1" colspan="1">15 (51.7%)</td><td rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td rowspan="1" colspan="1">Diuretics, n (%)</td><td rowspan="1" colspan="1">81 (63.3%)</td><td rowspan="1" colspan="1">106 (84.1%)</td><td rowspan="1" colspan="1">19 (50.0%)</td><td rowspan="1" colspan="1">25 (78.1%)</td><td rowspan="1" colspan="1">27 (100%)</td><td rowspan="1" colspan="1">29 (100%)</td><td rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Statins, n (%)</td><td rowspan="1" colspan="1">128 (100%)</td><td rowspan="1" colspan="1">94 (74.6%)</td><td rowspan="1" colspan="1">33 (86.8%)</td><td rowspan="1" colspan="1">28 (87.5%)</td><td rowspan="1" colspan="1">22 (81.5%)</td><td rowspan="1" colspan="1">11 (37.9%)</td><td rowspan="1" colspan="1">&#x0003c;0.05</td></tr><tr><td rowspan="1" colspan="1">Metformin, n (%)</td><td rowspan="1" colspan="1">43 (33.6%)</td><td rowspan="1" colspan="1">41 (32.5%)</td><td rowspan="1" colspan="1">9 (23.7%)</td><td rowspan="1" colspan="1">11 (34.3%)</td><td rowspan="1" colspan="1">12 (44.4%)</td><td rowspan="1" colspan="1">9 (31.0%)</td><td rowspan="1" colspan="1">0.054</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095478045648"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.b.f.d.a"><p class="p p-first-last">
Note: CI, confidence interval; ACEI, angiotensin-converting enzyme inhibitor; ARBs, angiotensin-2 receptor blockers.
</p></div></div></div></div><div id="s3-2" class="sec"><h3 id="s3-2title">
Circulating MPCs level in the study patient population
</h3><p class="p p-first">
<a href="/pmc/articles/PMC4195965/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a> shows the prevalence of various phenotypes of CD34<sup>+</sup>MPCs in the peripheral blood. Subjects with higher SUA quartile had significantly lower MPCs counts when compared with patient with low quartiles. CD45<sup>+</sup>CD34<sup>+</sup> cell count was positively correlated to the LVEF (r=0.686; P=0.001), negatively correlated to the &#x00415;/&#x00410;m ratio (r=-0.566; P=0.001), the &#x00415;/&#x00415;m ratio (r=-0.568; P=0.001). CD45<sup>+</sup>CD34<sup>+</sup> cell count was also correlated negatively to eGFR (r=-0.561; P=0.025), SUA (r=-0.482; P&#x0003c;0.001), and the NT-pro-BNP concentrations (r=-0.353; P&#x0003c;0.001).
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T3"><h3>
Table 3
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
Concentrations of MPCs in study patient population
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="2" colspan="1">
<strong>Cell phenotypes</strong>
</td><td rowspan="2" colspan="1">
<strong>Patients without</strong>
<br />
<strong> CHF (n=128)</strong>
</td><td colspan="5" align="center" rowspan="1">
<strong>Patients with CHF (n=126)</strong>
</td><td rowspan="2" colspan="1">
<strong>P</strong>
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Entire cohort patients</strong>
<br />
<strong>with CHF (n=126)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile I (19.06-</strong>
<br />
<strong>22.33 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile II (23.2-</strong>
<br />
<strong>31.10 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile III (32.0</strong>
<br />
<strong>-39.0 mmol/L)</strong>
</td><td rowspan="1" colspan="1">
<strong>Quartile IV (40.00</strong>
<br />
<strong> - 49.60 mmol/L)</strong>
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
CD45<sup>+</sup>CD34<sup>+</sup>&#x000d7;10<sup>-4</sup> , %
</td><td rowspan="1" colspan="1">2.191 (1.76&#x02013;2.613)</td><td rowspan="1" colspan="1">1.282 (1.21&#x02013;1.528)</td><td rowspan="1" colspan="1">1.77 (1.58&#x02013;1.93)</td><td rowspan="1" colspan="1">1.72 (1.53&#x02013;1.91)</td><td rowspan="1" colspan="1">1.45 (1.21&#x02013;1.68)</td><td rowspan="1" colspan="1">1.05 (0.80&#x02013;1.17)</td><td rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td rowspan="1" colspan="1">
CD45-CD34<sup>+</sup>&#x000d7;10<sup>-4</sup>, %
</td><td rowspan="1" colspan="1">1.09 (1.00&#x02013;1.348)</td><td rowspan="1" colspan="1">0.727 (0.54&#x02013;0.913)</td><td rowspan="1" colspan="1">1.01 (0.91&#x02013;1.15)</td><td rowspan="1" colspan="1">0.91 (0.81&#x02013;1.01)</td><td rowspan="1" colspan="1">0.83 (0.72&#x02013;0.93)</td><td rowspan="1" colspan="1">0.63 (0.33&#x02013;0.86)</td><td rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
CD14<sup>+</sup>CD309<sup>+</sup> &#x000d7;10<sup>-4</sup>, %
</td><td rowspan="1" colspan="1">57.00 (43.20&#x02013;81.50)</td><td rowspan="1" colspan="1">29.18 (15.00&#x02013;34.50)</td><td rowspan="1" colspan="1">43.9 (33.7&#x02013;54.12)</td><td rowspan="1" colspan="1">37.2 (28.8&#x02013;45.59)</td><td rowspan="1" colspan="1">28.0 (17.48&#x02013;37.2)</td><td rowspan="1" colspan="1">14.0 (11.1&#x02013;19.86)</td><td rowspan="1" colspan="1">0.01</td></tr><tr><td rowspan="1" colspan="1">
CD14<sup>+</sup>CD309<sup>+</sup>Tie<sup>+2</sup>&#x000d7;10<sup>-4</sup>, %
</td><td rowspan="1" colspan="1">5.50 (3.05&#x02013;8.15)</td><td rowspan="1" colspan="1">0.67 (0.21&#x02013;1.10)</td><td rowspan="1" colspan="1">0.86 (0.74&#x02013;0.98)</td><td rowspan="1" colspan="1">0.82 (0.73&#x02013;0.92)</td><td rowspan="1" colspan="1">0.67 (0.58&#x02013;0.76)</td><td rowspan="1" colspan="1">0.37 (0.29&#x02013;0.56)</td><td rowspan="1" colspan="1">0.01</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095488364368"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.c.c.d.a"><p class="p p-first-last">
Note: The values correspond to medians and a interquartile range (IQR) of 25%&#x02013;75%. Statistical comparisons are made using Mann-Whitney test with significance levels of 0.05 and 0.01 (for 2-tailed).
</p></div></div></div><p class="p p-last">
On the other hand, CD45-CD34<sup>+</sup> cell count in the peripheral blood was negatively associated with T2DM (r= -0.614; P&#x0003c;0.001), SUA (r=-0.466; P&#x0003c;0.001), hypertension (r=-0.240; P=0.026), the NT-pro-BNP level (r=-0.605; P=0.002), eGFR (r=-0.423; P=0.012), active smoking (r=-0.222; P=0.040). A positive association was found between the CD45-CD34<sup>+</sup> cell count and LVEF (r=0.723; P&#x0003c;0.001), the &#x00415;/&#x00410;m ratio (r=0.52; P=0.0024) and the &#x00415;/&#x00415;m ratio (r=0.60; P&#x0003c;0.001). The CD14<sup>+</sup>CD309<sup>+</sup> subpopulation count was associated positively with LVEF (r=0.785; P&#x0003c;0.001), the &#x00415;/&#x00415;m ratio (r=0.52; P&#x0003c;0.001), the &#x00415;/&#x00410;m ratio (r=0.48; P&#x0003c;0.001); and it was associated negatively with the NYHA class (r=-0.622; P=0.001), T2DM (r= -0.521; P=0.001), SUA (r=-0.508; P=0.001), NT-pro-BNP level (r=-0.362; P=0.001), hypertension (r=-0.320; P=0.005), the total cholesterol level (r=-0.260; P=0.04), adherence to smoking (r=-0.259; P=0.042) and patient&#x02019;s age (r=-0.254; P=0.002). The CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> subpopulation count showed a positive association with LVEF (r=0.639; P=0.001), the &#x00415;/&#x00415;m ratio (r=0.52; P=0.001), eGFR (r=0.486; P=0.002); and a negative association with the NYHA class (r=-0.657; P=0.001), SUA (r=-0.628; P=0.001), T2DM (r=-0.610; P=0.001), the NT-pro-BNP level (r=-0.373; P=0.001), the serum concentrations of low<strong>-</strong>density lipoproteins (r=-0.354; P=0.001), the TG level (r=-0.258; P=0.043), adherence to smoking (r=-0.285; P=0.042), the body mass index (r=-0.272; P=0.046).
</p></div><div id="s3-3" class="sec"><h3 id="s3-3title">
Association between SUA level and biomarkers
</h3><p class="p p-first">
SUA levels positively correlated with NYHA functional class (r=0.612; P&#x0003c;0.001); T2DM (r=0.462; P&#x0003c;0.001), NT-pro-BNP (r=0.612; P&#x0003c;0.001), diuretics (r = 0.37, P&#x0003c;0.01), body mass index (r= 0.34, P&#x0003c;0.05), hyperlipidemia (r= 0.32, P&#x0003c;0.05), age (r= 0.30, P&#x0003c;0.01), male gender (r= 0.29, P&#x0003c;0.05), and inversely correlated with eGFR (r= -0.476; P=0.002), LVEF (r= -0.42; P=0.001), CD45<sup>+</sup>CD34<sup>+</sup> MPCs (r= -0.388; P=0.001); CD45-CD34<sup>+</sup> MPCs (r= -0.41; P=0.001); CD14<sup>+</sup>CD309<sup>+</sup> MPCs (r= -0.397; P=0.001); CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs (r= -0.442; P=0.001). Multivariable linear regression analyses were performed for CD34<sup>+</sup>phenotypes of MPCs, adjusted for eGFR, BMI, LVEF, NYHA, diuretics, and T2DM. SUA level independently impacted the count of CD14<sup>+</sup>CD309<sup>+</sup> cells (r= -0.388; P=0.001) and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> cells (r= -0.414; P=0.001), while it had no impact on the number of CD45<sup>+</sup>CD34<sup>+</sup> cells (r= -0.214; P=0.22) and CD45-CD34<sup>+</sup> cells (r= -0.16; P=0.16). The higher quartiles (Q3 and Q4) compared to the lower quartiles (Q1 and Q2) were associated with increased risk of cell depletion of both CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs among CHF patients, while such a drop was not observed in non-CHF subjects (<a href="/pmc/articles/PMC4195965/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>Table 4</span></a>).
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T4"><h3>
Table 4
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
Cox proportional adjusted Odds Ratios analyses for CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs by SUA Quartiles
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="2" colspan="1">
</td><td rowspan="2" colspan="1">
<strong>SUA Quartiles</strong>
</td><td colspan="2" align="center" rowspan="1">
<strong>SUA, mmol/L</strong>
</td><td rowspan="2" colspan="1">
<strong>Odds Ratio</strong>
</td><td rowspan="2" colspan="1">
<strong>95% CI</strong>
</td><td rowspan="2" colspan="1">
<strong>P value</strong>
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Median</strong>
</td><td rowspan="1" colspan="1">
<strong>95% CI</strong>
</td></tr><tr style="background-color:#fdeae6"><td rowspan="1" colspan="1">
<strong>For CHF patients</strong>
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
For CD14<sup>+</sup>CD309<sup>+</sup> MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q1</td><td rowspan="1" colspan="1">20.11</td><td rowspan="1" colspan="1">19.06-22.33 </td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q2</td><td rowspan="1" colspan="1">27.53</td><td rowspan="1" colspan="1">23.2-31.10 </td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">0.88-1.11</td><td rowspan="1" colspan="1">0.24</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q3</td><td rowspan="1" colspan="1">35.80</td><td rowspan="1" colspan="1">32.0-39.0 </td><td rowspan="1" colspan="1">1.18</td><td rowspan="1" colspan="1">1.06-1.29</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q4</td><td rowspan="1" colspan="1">44.90</td><td rowspan="1" colspan="1">40.00-49.60</td><td rowspan="1" colspan="1">1.24</td><td rowspan="1" colspan="1">1.12-1.46</td><td rowspan="1" colspan="1">0.002</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
For CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q1</td><td rowspan="1" colspan="1">20.11</td><td rowspan="1" colspan="1">19.06-22.33 </td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q2</td><td rowspan="1" colspan="1">27.53</td><td rowspan="1" colspan="1">23.2-31.10 </td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">1.00-1.20</td><td rowspan="1" colspan="1">0.054</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q3</td><td rowspan="1" colspan="1">35.80</td><td rowspan="1" colspan="1">32.0-39.0 </td><td rowspan="1" colspan="1">1.22</td><td rowspan="1" colspan="1">1.11-1.34</td><td rowspan="1" colspan="1">0.001</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none ;background-color:#fef3f4"><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q4</td><td rowspan="1" colspan="1">44.90</td><td rowspan="1" colspan="1">40.00-49.60</td><td rowspan="1" colspan="1">1.38</td><td rowspan="1" colspan="1">1.20-1.55</td><td rowspan="1" colspan="1">0.001</td></tr><tr style="background-color:#fdeae6"><td rowspan="1" colspan="1">
<strong>For non-CHF patients</strong>
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
For CD14<sup>+</sup>CD309<sup>+</sup> MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q1</td><td rowspan="1" colspan="1">20.21</td><td rowspan="1" colspan="1">18.18-22.50</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q2</td><td rowspan="1" colspan="1">25.82</td><td rowspan="1" colspan="1">23.1-27.60</td><td rowspan="1" colspan="1">1.01</td><td rowspan="1" colspan="1">0.83-1.16</td><td rowspan="1" colspan="1">0.16</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q3</td><td rowspan="1" colspan="1">30.60</td><td rowspan="1" colspan="1">28.3-32.7</td><td rowspan="1" colspan="1">1.04</td><td rowspan="1" colspan="1">0.92-1.15</td><td rowspan="1" colspan="1">0.12</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q4</td><td rowspan="1" colspan="1">34.50</td><td rowspan="1" colspan="1">33.20-37.50</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">0.96-1.18</td><td rowspan="1" colspan="1">0.22</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
For CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q1</td><td rowspan="1" colspan="1">20.21</td><td rowspan="1" colspan="1">18.18-22.50</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q2</td><td rowspan="1" colspan="1">25.82</td><td rowspan="1" colspan="1">23.1-27.60</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">0.92-1.10</td><td rowspan="1" colspan="1">0.44</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q3</td><td rowspan="1" colspan="1">30.60</td><td rowspan="1" colspan="1">28.3-32.7</td><td rowspan="1" colspan="1">1.06</td><td rowspan="1" colspan="1">0.95-1.12</td><td rowspan="1" colspan="1">0.32</td></tr><tr><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">Q4</td><td rowspan="1" colspan="1">34.50</td><td rowspan="1" colspan="1">33.20-37.50</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">0.94-1.11</td><td rowspan="1" colspan="1">0.26</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095524561696"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.d.c.d.a"><p class="p p-first">
Note: All the respective biomarker-models are adjusted for eGFR, BMI, LVEF, NYHA, diuretics, and T2DM.
</p><p class="p p-last">
Abbreviations: Q, quartile; MPCs, mononuclear progenitor cells; SUA, serum uric acid; eGFR, estimated glomerular filtration ratio; BMI,
body mass index; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; T2DM, type two diabetes mellitus.
</p></div></div></div></div><div id="s3-4" class="sec sec-last"><h3 id="s3-4title">
The predictive value of SUA
</h3><p class="p p-first">
The predictive value of SUA level with respect to the MPCs with phenotypes CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>in the patients with CHF was performed using ROC-analysis, the results of which are presented in <a href="/pmc/articles/PMC4195965/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>. SUA demonstrated a high predictive value for declining both MPC phenotypes (CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>)in CHF patients. The estimated areas under the curves (AUC) were 0.631 (sensitivity= 63.9%; specificity= 56.2%) for CD14<sup>+</sup>CD309<sup>+</sup> cells and 0.687 (sensitivity= 72.2%; specificity= 52.9%) for CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> cell population. The cut-off value for the SUA level that predicted the cell loss best in both models was 31.5 mmol/L. Of all the variables (SUA, eGFR, BMI, LVEF, NYHA, diuretics, and T2DM) included in our multivariate model, SUA was the strongest predictor of proangiogenic MPCs depletion. However, the addition of SUA over cut-off point to the ABC model improved the relative IDI by 13.8% for depletion of CD14<sup>+</sup>CD309<sup>+</sup> MPCs and by 14.5% for depletion of CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>MPCs (<a href="/pmc/articles/PMC4195965/table/T5/" target="table" class="fig-table-link figpopup" rid-figpopup="T5" rid-ob="ob-T5" co-legend-rid=""><span>Table 5</span></a>). For category-free NRI, 16% of events (P=0.001) and 19% of non-events (P=0.0001) were correctly reclassified by the addition of SUA to the ABC model for depletion of CD14<sup>+</sup>CD309<sup>+</sup> cells (<a href="/pmc/articles/PMC4195965/table/T6/" target="table" class="fig-table-link figpopup" rid-figpopup="T6" rid-ob="ob-T6" co-legend-rid=""><span>Table 6</span></a>). When we added Q4 SUA to the ABC model, 18% of events (P=0.001) and 24% of non-events (P=0.0012) were reclassified for depletion of CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>cells. Thus, these data suggest that elevation of SUA might be considered a predictor of proangiogenic MPCs loss in patients with CHF.
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4195965/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140095486873840"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is JCVTR-6-153-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is JCVTR-6-153-g001.jpg" src="/pmc/articles/PMC4195965/bin/JCVTR-6-153-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140095486873840"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4195965/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">
Figure 1
</a></div><div class="statement" id="statement-a.p.c.e.c.c"><p>
The predictive power of SUA in the both models for declining of CD14<sup>+</sup>CD309<sup>+</sup> and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs in CHF patients. Results of the Receive Operation Characteristics analysis.
</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T5"><h3>
Table 5
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
C-statistics for Models with SUA, eGFR, BMI, LVEF, NYHA, diuretics, and T2DM as Continuous Variables
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Models</strong>
</td><td rowspan="1" colspan="1">
<strong>AUC (95% CI)</strong>
</td><td rowspan="1" colspan="1">
<strong>&#x00394;AUC</strong>
</td><td rowspan="1" colspan="1">
<strong>IDI (&#x000b1;SE)</strong>
</td><td rowspan="1" colspan="1">
<strong>Relative IDI (%)</strong>
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
Depletion of CD14<sup>+</sup>CD309<sup>+</sup> MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">Model 1 (eGFR, BMI, LVEF, NYHA, diuretics, and T2DM)</td><td rowspan="1" colspan="1">0.528</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Model 1 + Q4 SUA</td><td rowspan="1" colspan="1">0.664</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Model 1 + Q4 SUA vs Model 1</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0.136; P=0.001</td><td rowspan="1" colspan="1">0.05&#x000b1;0.015</td><td rowspan="1" colspan="1">13.8%</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
Depletion of CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>MPCs
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">Model 1 (eGFR, BMI, LVEF, NYHA, diuretics, and T2DM)</td><td rowspan="1" colspan="1">0.516</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Model 1 + Q4 SUA</td><td rowspan="1" colspan="1">0.672</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">Model 1 + Q4 SUA vs Model 1</td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">0.156; P=0.001</td><td rowspan="1" colspan="1">0.06&#x000b1;0.012</td><td rowspan="1" colspan="1">14.5%</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095483002768"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.e.d.d.a"><p class="p p-first">
Note: Relative IDI &#x02013; calculated as the ratio of IDI over the discrimination slope of the model without Q4 SUA (less than cut-off point equal 31.5 mmol/L of SUA).
</p><p class="p p-last">Abbreviations: AUC, area under curve; SE, standard error; IDI, integrated discrimination index; NRI, net reclassification improvement; MPCs, mononuclear progenitor cells; SUA, serum uric acid; eGFR, estimated glomerular filtration ratio; BMI, body mass index; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; T2DM, type two diabetes mellitus.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T6"><h3>
Table 6
</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>
Prediction performance analyses for models with SUA, eGFR, BMI, LVEF, NYHA, diuretics, and T2DM as continuous variables
</strong></div><div class="xtable"><table frame="hsides" rules="none" class="rendered small default_table"><tbody><tr style="border-width: 0px 0px 1pt 0px ; border-style: none none solid none"><td rowspan="1" colspan="1">
<strong>Model 2 vs model 1</strong>
</td><td rowspan="1" colspan="1">
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">
Depletion of CD14<sup>+</sup>CD309<sup>+</sup> MPCs
</td><td rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">Categorical NRI</td><td rowspan="1" colspan="1">0.11 (95% CI 0.07-0.14)</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Percentage of events correctly reclassified</td><td rowspan="1" colspan="1">5 (P=0.11)</td></tr><tr><td rowspan="1" colspan="1">Percentage of non-events correctly reclassified</td><td rowspan="1" colspan="1">5 (P=0.012)</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Categorical free NRI</td><td rowspan="1" colspan="1">0.42 (95% CI 0.26-0.54)</td></tr><tr><td rowspan="1" colspan="1">Percentage of events correctly reclassified</td><td rowspan="1" colspan="1">16% (P=0.001)</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Percentage of non-events correctly reclassified</td><td rowspan="1" colspan="1">19% (P=0.0001)</td></tr><tr><td rowspan="1" colspan="1">
Depletion of CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup>MPCs
</td><td rowspan="1" colspan="1">
</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Categorical NRI</td><td rowspan="1" colspan="1">0.14 (95% CI 0.10-0.19)</td></tr><tr><td rowspan="1" colspan="1">Percentage of events correctly reclassified</td><td rowspan="1" colspan="1">6 (P =0.14)</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Percentage of non-events correctly reclassified</td><td rowspan="1" colspan="1">8 (P =0.010)</td></tr><tr><td rowspan="1" colspan="1">Categorical free NRI</td><td rowspan="1" colspan="1">0.48 (95% CI 0.29-0.62)</td></tr><tr style="background-color:#fef3f4"><td rowspan="1" colspan="1">Percentage of events correctly reclassified</td><td rowspan="1" colspan="1">18% (P=0.001)</td></tr><tr><td rowspan="1" colspan="1">Percentage of non-events correctly reclassified</td><td rowspan="1" colspan="1">24% (P =0.0012)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140095482908368"><a target="object" rel="noopener" href="/pmc/articles/PMC4195965/table/T6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.p.c.e.e.d.a"><p class="p p-first">
Note: Model 1- eGFR, BMI, LVEF, NYHA, diuretics, and T2DM; Model 2 - eGFR, BMI, LVEF, NYHA, diuretics, T2DM and Q4 SUA.
</p><p class="p p-last">
Abbreviations: NRI, net reclassification improvement; MPCs, mononuclear progenitor cells; SUA, serum uric acid; eGFR, estimated glomerular filtration ratio; BMI, body mass index; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; T2DM, type two diabetes mellitus.
</p></div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p class="p p-first">
Previous reports have been predominantly elucidated a relationship between cardiovascular outcomes and documented hyperuricemia in patients with acute and CHF.<sup><a href="#R3" rid="R3" class=" bibr popnode">3</a>,<a href="#R22" rid="R22" class=" bibr popnode">22</a>,<a href="#R23" rid="R23" class=" bibr popnode">23</a></sup> The effects of SUA on all-cause mortality at different SUA cut-off levels in CHF patient population were evaluated using meta-regression. There was a linear association between SUA after 7 mg/dL (41.6 mmol/L) and mortality.<sup><a href="#R24" rid="R24" class=" bibr popnode">24</a></sup> Arguing against a pure protective role of SUA in cardiovascular disease<sup><a href="#R25" rid="R25" class=" bibr popnode">25</a></sup> , we found that levels of SUA remained independently associated with depletion of proangiogenic MPCs after adjusting for parameters with known effects. These cells play critical role in tissue repair and neovascularization due to their angiogenic property. Elevated levels of SUA in CHF patient population were associated with progressively declining proangiogenic MPC.
</p><p>
These findings add to the existing controversy on the role of SUA in the evolution of CHF and its related outcomes. Elevated levels of SUA have been linked to the body habitus, diuretic use, declining eGFR, as wells as both biochemical (NT-pro-BNP) and hemodynamic (E/Ea and LVEF) markers of CHF by several investigators.<sup><a href="#R24" rid="R24" class=" bibr popnode">24</a>,<a href="#R26" rid="R26" class=" bibr popnode">26</a></sup> Amin et al reported that even mild elevation of SUA is associated with impaired clinical and hemodynamic profile in patients with systolic CHF and suggested that SUA might be used as a non-invasive indicator of elevated left ventricular filling pressures.<sup><a href="#R27" rid="R27" class=" bibr popnode">27</a></sup> Misra et al demonstrated a reverse impact of CHF status (compensation or decompensation) on SUA levels among men with high cardiovascular risk profile.<sup><a href="#R28" rid="R28" class=" bibr popnode">28</a></sup> These investigators found that mild elevated SUA associated with increased risk of CHF decompensation (OR = 1.67; 95% CI 1.21 to 2.32).
</p><p>
Although hyperuricemia predominantly affects men, our findings failed to show differences in SUA between men and women diagnosed with CHF. According to our findings, there was no documented case of hyperuricemia (defined as SUA &#x02265;6 mg/dL for women [35.6 mmol/L] and &#x02265;8 mg/dL for men [47.6 mmol/L]). Moreover, none of our patients was treated for symptomatic hyperuricemia. However, the interpretation of SUA levels for individuals with CHF may be confusing, as even a small increase in SUA levels is probably viewed as a marker of endothelial dysfunction and an indicator of tissue repair in symptomatic CHF patients. Current evidence suggests that SUA could be a marker of oxidative damage in several settings associated with CHF, such as overweight, obesity, diuretic use. Although we described a modest linear association between SUA and body habitus and between SUA and diuretic use as we failed to show any correlation between these variables and the number of circulating MPCs.
</p><p>
It has predisposed that SUA may realize their antioxidative capacity. Therefore, it is not clear whether this increase in SUA levels may be an epiphenomenon, a counter-regulatory process or a detrimental factor that is contributing to the underlying pathophysiology. Since uric acid is a byproduct of purine catabolism and its serum levels increase as the enzymatic activity of xanthine oxidase surges in tissue hypoxia and subsequent apoptosis in CHF settings.<sup><a href="#R29" rid="R29" class=" bibr popnode">29</a></sup>
</p><p>
The association between hyperuricemia and poor outcomes of CHF is more noticeable in patients without renal dysfunction than those with CKD.<sup><a href="#R29" rid="R29" class=" bibr popnode">29</a>-<a href="#R31" rid="R31" class=" bibr popnode">31</a></sup> This finding suggests that hyperuricemia may predict poor outcomes when it primarily increased due to enhanced oxidative activity rather than the conditions where its renal excretion is impaired.<sup><a href="#R30" rid="R30" class=" bibr popnode">30</a></sup> Conversely Filippatos et al have found no association between SUA and BMI, as it is the case with our report.<sup><a href="#R29" rid="R29" class=" bibr popnode">29</a></sup> Diuretics, mainly the hydrochlorothiazides, are widely used to treat CHF, meanwhile elevating serum concentrations of uric acid by increasing the reabsorption of sodium and urate in the proximal tubule. Although we reported an association between SUA and diuretics administration, the direct effect of diuretics in depletion of MPCs in patient study population was not determined.
</p><p class="p p-last">
SUA may associate with CAD through its effect on coronary risk factors, such as obesity, hypertension, hypertriglyceridemia, dyslipidaemia and T2DM. Multivariate linear regression model that was constructed for CD34<sup>+</sup>phenotypes of MPCs demonstrated that even following an adjustment for eGFR, LVEF, NYHA functional class, diuretics, and T2DM, SUA had an independent impact of on the cell count of CD14<sup>+</sup>CD309<sup>+</sup> MPCs and CD14<sup>+</sup>CD309<sup>+</sup>Tie2<sup>+</sup> MPCs. We speculate that tissue ischemia results in enhanced oxidative activity of xanthine oxidase and subsequent production of uric acid. The observed suppression in recruitment, mobbing, differentiation and functional status of MPCs are mediated through Akt/STAT/MAP-kinase mechanisms as a reflection of chronic oxidative stress and probably, enhanced catabolic state in CHF.<sup><a href="#R32" rid="R32" class=" bibr popnode">32</a>-<a href="#R34" rid="R34" class=" bibr popnode">34</a></sup> It is possible to address to new investigations whether relationships between SUA and proangiogenic MPCs are multidimensional, or if they can be associated with clinical outcomes.
</p></div><div id="s5" class="tsec sec"><h2 class="head no_bottom_margin" id="s5title">Conclusion</h2><p class="p p-first-last">
Circulating level of proangiogenic MPCs declines progressively depended on quartiles of SUA level in CHF subjects. We suggest that mild elevation of SUA (&#x0003e;31.5 mmol/L) might be considered a predictor of decline in the number of proangiogenic MPCs in patients diagnosed with CHF.
</p></div><div id="s6" class="tsec sec"><h2 class="head no_bottom_margin" id="s6title">Study restrictions</h2><p class="p p-first-last">
This study has some restrictions. The authors believe that a greater cohort is to be desirable to improve the power of the study. There is a variation in the definition of EPCs, the number of existing cardiovascular risk factors in various patients, and in the interaction between EPCs and other hematopoietic progenitor, inflammatory cells or platelets. The authors suppose that these restrictions might have no significant impact on the study data interpretation.
</p></div><div id="s7" class="tsec sec"><h2 class="head no_bottom_margin" id="s7title">Acknowledgements</h2><p class="p p-first-last">
We thank all patients for their participation in the investigation, staff of the Regional Zaporozhye Hospital (Ukraine) and the doctors, nurses, and administrative staff in City hospital # 6 (Zaporozhye, Ukraine), general practices, and site-managed organizations that assisted with the study.
</p></div><div id="s8" class="tsec sec"><h2 class="head no_bottom_margin" id="s8title">Ethical Issues</h2><p class="p p-first-last">
The study was approved by an institutional review committee. The investigators followed strictly all the requirements to clinical trials in conformity with the World Medical Association Declaration of Helsinki, 1964, 2008, good clinical practice provided by International Conference on Harmonization (GCP-ICH), Council of Europe Convention for the Protection of Human Rights and Dignity of the Human Being in view of using achievements in biology and medicine, convention on Human Rights and Biomedicine, including Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research, and legislation of Ukraine.
</p></div><div id="s9" class="tsec sec"><h2 class="head no_bottom_margin" id="s9title">Competing interests</h2><p class="p p-first-last">
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The Authors declare that they have no competing interests.
</p></div><div id="ref-list-a.q.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.q.atitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Santulli G. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. <span><span class="ref-journal">JCvD. </span>2013;<span class="ref-vol">1</span>:1–2.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JCvD&amp;title=Epidemiology+of+cardiovascular+disease+in+the+21st+century:+updated+numbers+and+updated+facts&amp;author=G+Santulli&amp;volume=1&amp;publication_year=2013&amp;pages=1-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Gustafsson D, Unwin R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. <span><span class="ref-journal">BMC Nephrol. </span>2013;<span class="ref-vol">14</span>:164.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3750299/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23895142" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Nephrol&amp;title=The+pathophysiology+of+hyperuricaemia+and+its+possible+relationship+to+cardiovascular+disease,+morbidity+and+mortality&amp;author=D+Gustafsson&amp;author=R+Unwin&amp;volume=14&amp;publication_year=2013&amp;pages=164&amp;pmid=23895142&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. <span><span class="ref-journal">Rheumatology (Oxford) </span>2013;<span class="ref-vol">52</span>:127–134.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22923756" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology+(Oxford)&amp;title=Significance+of+serum+uric+acid+levels+on+the+risk+of+all-cause+and+cardiovascular+mortality&amp;author=CF+Kuo&amp;author=LC+See&amp;author=KH+Yu&amp;author=IJ+Chou&amp;author=MJ+Chiou&amp;volume=52&amp;publication_year=2013&amp;pages=127-134&amp;pmid=22923756&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Huang H, Huang B, Li Y, Huang Y, Li J, Yao H. et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. <span><span class="ref-journal">Eur J Heart Fail. </span>2014;<span class="ref-vol">16</span>:15–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23933579" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Heart+Fail&amp;title=Uric+acid+and+risk+of+heart+failure:+a+systematic+review+and+meta-analysis&amp;author=H+Huang&amp;author=B+Huang&amp;author=Y+Li&amp;author=Y+Huang&amp;author=J+Li&amp;volume=16&amp;publication_year=2014&amp;pages=15-24&amp;pmid=23933579&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. <span><span class="ref-journal">Congest Heart Fail. </span>2011;<span class="ref-vol">17</span>:25–30.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21272224" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Congest+Heart+Fail&amp;title=Uric+acid+as+a+predictor+of+all-cause+mortality+in+heart+failure:+a+meta-analysis&amp;author=L+Tamariz&amp;author=A+Harzand&amp;author=A+Palacio&amp;author=S+Verma&amp;author=J+Jones&amp;volume=17&amp;publication_year=2011&amp;pages=25-30&amp;pmid=21272224&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Jeemon P, Prabhakaran D. Does uric acid qualify as an independent risk factor for cardiovascular mortality? <span><span class="ref-journal">Clin Sci (Lond) </span>2013;<span class="ref-vol">124</span>:255–257.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23043434" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Sci+(Lond)&amp;title=Does+uric+acid+qualify+as+an+independent+risk+factor+for+cardiovascular+mortality?&amp;author=P+Jeemon&amp;author=D+Prabhakaran&amp;volume=124&amp;publication_year=2013&amp;pages=255-257&amp;pmid=23043434&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Rehman J, Li J, Orschell CM, March KL. Peripheral blood &#x0201c;endothelial progenitor cells&#x0201d; are derived from monocyte/macrophages and secrete angiogenic growth factors. <span><span class="ref-journal">Circulation. </span>2003;<span class="ref-vol">107</span>:1164–1169.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12615796" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Peripheral+blood+&#x0201c;endothelial+progenitor+cells&#x0201d;+are+derived+from+monocyte/macrophages+and+secrete+angiogenic+growth+factors&amp;author=J+Rehman&amp;author=J+Li&amp;author=CM+Orschell&amp;author=KL+March&amp;volume=107&amp;publication_year=2003&amp;pages=1164-1169&amp;pmid=12615796&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Schmidt-Lucke C, R&#x000f6;ssig L, Fichtlscherer S, Vasa M, Britten M, K&#x000e4;mper U. et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. <span><span class="ref-journal">Circulation. </span>2005;<span class="ref-vol">111</span>:2981–2987.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15927972" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Reduced+number+of+circulating+endothelial+progenitor+cells+predicts+future+cardiovascular+events:+proof+of+concept+for+the+clinical+importance+of+endogenous+vascular+repair&amp;author=C+Schmidt-Lucke&amp;author=L+R&#x000f6;ssig&amp;author=S+Fichtlscherer&amp;author=M+Vasa&amp;author=M+Britten&amp;volume=111&amp;publication_year=2005&amp;pages=2981-2987&amp;pmid=15927972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:593–600.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12584367" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Circulating+endothelial+progenitor+cells,+vascular+function,+and+cardiovascular+risk&amp;author=JM+Hill&amp;author=G+Zalos&amp;author=JP+Halcox&amp;author=WH+Schenke&amp;author=MA+Waclawiw&amp;volume=348&amp;publication_year=2003&amp;pages=593-600&amp;pmid=12584367&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P. et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">110</span>:1209–1212.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15249502" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=CD34++and+endothelial+progenitor+cells+in+patients+with+various+degrees+of+congestive+heart+failure&amp;author=M+Valgimigli&amp;author=GM+Rigolin&amp;author=A+Fucili&amp;author=MD+Porta&amp;author=O+Soukhomovskaia&amp;volume=110&amp;publication_year=2004&amp;pages=1209-1212&amp;pmid=15249502&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U. et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. <span><span class="ref-journal">J Am Coll Cardiol. </span>2007;<span class="ref-vol">49</span>:2341–2349.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17572250" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=Selective+functional+exhaustion+of+hematopoietic+progenitor+cells+in+the+bone+marrow+of+patients+with+postinfarction+heart+failure&amp;author=CK+Kissel&amp;author=R+Lehmann&amp;author=B+Assmus&amp;author=A+Aicher&amp;author=J+Honold&amp;volume=49&amp;publication_year=2007&amp;pages=2341-2349&amp;pmid=17572250&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S. et al. Circulating progenitor cell count for cardiovascular risk strati&#x0fb01;cation: a pooled analysis. <span><span class="ref-journal">PLoS One. </span>2010;<span class="ref-vol">5</span>:e11488.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2901328/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20634884" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Circulating+progenitor+cell+count+for+cardiovascular+risk+strati&#x0fb01;cation:+a+pooled+analysis&amp;author=GP+Fadini&amp;author=S+Maruyama&amp;author=T+Ozaki&amp;author=A+Taguchi&amp;author=J+Meigs&amp;volume=5&amp;publication_year=2010&amp;pages=e11488&amp;pmid=20634884&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Fritzenwanger M, Lorenz F, Jung C, Fabris M, Thude H, Barz D. et al. Differential number of cd34+, cd133+ and cd34+/cd133+ cells in peripheral blood of patients with congestive heart failure. <span><span class="ref-journal">Eur J Med Res. </span>2009;<span class="ref-vol">14</span>:113–117.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3352059/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19380281" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Med+Res&amp;title=Differential+number+of+cd34+,+cd133++and+cd34+/cd133++cells+in+peripheral+blood+of+patients+with+congestive+heart+failure&amp;author=M+Fritzenwanger&amp;author=F+Lorenz&amp;author=C+Jung&amp;author=M+Fabris&amp;author=H+Thude&amp;volume=14&amp;publication_year=2009&amp;pages=113-117&amp;pmid=19380281&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Bakogiannis C, Tousoulis D, Androulakis E, Briasoulis A, Papageorgiou N, Vogiatzi G. et al. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. <span><span class="ref-journal">Curr Med Chem. </span>2012;<span class="ref-vol">19</span>:2597–604.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22489718" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Med+Chem&amp;title=Circulating+endothelial+progenitor+cells+as+biomarkers+for+prediction+of+cardiovascular+outcomes&amp;author=C+Bakogiannis&amp;author=D+Tousoulis&amp;author=E+Androulakis&amp;author=A+Briasoulis&amp;author=N+Papageorgiou&amp;volume=19&amp;publication_year=2012&amp;pages=2597-604&amp;pmid=22489718&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B&#x000f6;hm M, Dickstein K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. <span><span class="ref-journal">Eur Heart J. </span>2012;<span class="ref-vol">33</span>:1787–1847.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22611136" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Heart+J&amp;title=ESC+Guidelines+for+the+diagnosis+and+treatment+of+acute+and+chronic+heart+failure+2012&amp;author=JJ+McMurray&amp;author=S+Adamopoulos&amp;author=SD+Anker&amp;author=A+Auricchio&amp;author=M+B&#x000f6;hm&amp;volume=33&amp;publication_year=2012&amp;pages=1787-1847&amp;pmid=22611136&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Bluemke DA, Achenbach S, Budoff M, Gerber TC, Gersh B, Hillis LD. et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. <span><span class="ref-journal">Circulation. </span>2008;<span class="ref-vol">118</span>:586–606.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18586979" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Noninvasive+coronary+artery+imaging:+magnetic+resonance+angiography+and+multidetector+computed+tomography+angiography:+a+scientific+statement+from+the+American+Heart+Association+Committee+on+Cardiovascular+Imaging+and+Intervention+of+the+Council+on+Cardiovascular+Radiology+and+Intervention,+and+the+Councils+on+Clinical+Cardiology+and+Cardiovascular+Disease+in+the+Young&amp;author=DA+Bluemke&amp;author=S+Achenbach&amp;author=M+Budoff&amp;author=TC+Gerber&amp;author=B+Gersh&amp;volume=118&amp;publication_year=2008&amp;pages=586-606&amp;pmid=18586979&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H. et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiographyAmerican Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. <span><span class="ref-journal">J Am Soc Echocardiogr. </span>1989;<span class="ref-vol">2</span>:358–367.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2698218" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Echocardiogr&amp;title=Recommendations+for+quantitation+of+the+left+ventricle+by+two-dimensional+echocardiographyAmerican+Society+of+Echocardiography+Committee+on+Standards,+Subcommittee+on+Quantitation+of+Two-Dimensional+Echocardiograms&amp;author=NB+Schiller&amp;author=PM+Shah&amp;author=M+Crawford&amp;author=A+DeMaria&amp;author=R+Devereux&amp;volume=2&amp;publication_year=1989&amp;pages=358-367&amp;pmid=2698218&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Pellerin D, Sharma R, Elliott P, Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. <span><span class="ref-journal">Heart. </span>2003;<span class="ref-vol">89</span>:iii9–17.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1876304/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14594870" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Heart&amp;title=Tissue+Doppler,+strain,+and+strain+rate+echocardiography+for+the+assessment+of+left+and+right+systolic+ventricular+function&amp;author=D+Pellerin&amp;author=R+Sharma&amp;author=P+Elliott&amp;author=C+Veyrat&amp;volume=89&amp;publication_year=2003&amp;pages=iii9-17&amp;pmid=14594870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI. et al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)A New Equation to Estimate Glomerular Filtration Rate. <span><span class="ref-journal">Ann Intern Med. </span>2009;<span class="ref-vol">150</span>:604–612.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2763564/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19414839" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Intern+Med&amp;title=for+the+CKD-EPI+(Chronic+Kidney+Disease+Epidemiology+Collaboration)A+New+Equation+to+Estimate+Glomerular+Filtration+Rate&amp;author=AS+Levey&amp;author=LA+Stevens&amp;author=CH+Schmid&amp;author=YL+Zhang&amp;author=3rd+Castro+AF&amp;volume=150&amp;publication_year=2009&amp;pages=604-612&amp;pmid=19414839&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. <span><span class="ref-journal">Clin Chem. </span>1972;<span class="ref-vol">18</span>:499–502.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/4337382" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Estimation+of+the+concentration+of+low-density+lipoprotein+cholesterol+in+plasma,+without+use+of+the+preparative+ultracentrifuge&amp;author=WT+Friedewald&amp;author=RI+Levy&amp;author=DS+Fredrickson&amp;volume=18&amp;publication_year=1972&amp;pages=499-502&amp;pmid=4337382&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Tung JW, Parks DR, Moore WA, Herzenberg LA, Herzenberg LA. New approaches to fluorescence compensation and visualization of FACS data. <span><span class="ref-journal">Clin Immunol. </span>2004;<span class="ref-vol">110</span>:277–283.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15047205" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;title=New+approaches+to+fluorescence+compensation+and+visualization+of+FACS+data&amp;author=JW+Tung&amp;author=DR+Parks&amp;author=WA+Moore&amp;author=LA+Herzenberg&amp;author=LA+Herzenberg&amp;volume=110&amp;publication_year=2004&amp;pages=277-283&amp;pmid=15047205&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">M&#x000e1;lek F, O&#x00161;&#x00165;&#x000e1;dal P, Pa&#x00159;enica J, Jarkovsk&#x000fd; J, V&#x000ed;tovec J, Widimsk&#x000fd; P. et al. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure-results of the Acute HEart FAilure Database registry. <span><span class="ref-journal">J Crit Care. </span>2012;<span class="ref-vol">27</span>:737 e11–24.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22699032" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Crit+Care&amp;title=Uric+acid,+allopurinol+therapy,+and+mortality+in+patients+with+acute+heart+failure-results+of+the+Acute+HEart+FAilure+Database+registry&amp;author=F+M&#x000e1;lek&amp;author=P+O&#x00161;&#x00165;&#x000e1;dal&amp;author=J+Pa&#x00159;enica&amp;author=J+Jarkovsk&#x000fd;&amp;author=J+V&#x000ed;tovec&amp;volume=27&amp;publication_year=2012&amp;pages=737+e11-24&amp;pmid=22699032&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Manzano L, Babalis D, Roughton M, Shibata M, Anker SD, Ghio S. et al. Predictors of clinical outcomes in elderly patients with heart failure. <span><span class="ref-journal">Eur J Heart Fail. </span>2011;<span class="ref-vol">13</span>:528–536.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21454299" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Heart+Fail&amp;title=Predictors+of+clinical+outcomes+in+elderly+patients+with+heart+failure&amp;author=L+Manzano&amp;author=D+Babalis&amp;author=M+Roughton&amp;author=M+Shibata&amp;author=SD+Anker&amp;volume=13&amp;publication_year=2011&amp;pages=528-536&amp;pmid=21454299&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. <span><span class="ref-journal">Congest Heart Fail. </span>2011;<span class="ref-vol">17</span>:25–30.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21272224" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Congest+Heart+Fail&amp;title=Uric+acid+as+a+predictor+of+all-cause+mortality+in+heart+failure:+a+meta-analysis&amp;author=L+Tamariz&amp;author=A+Harzand&amp;author=A+Palacio&amp;author=S+Verma&amp;author=J+Jones&amp;volume=17&amp;publication_year=2011&amp;pages=25-30&amp;pmid=21272224&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Alca&#x000ed;no H, Greig D, Castro P, Verdejo H, Mellado R, Garc&#x000ed;a L. et al. The role of uric acid in heart failure. <span><span class="ref-journal">Rev Med Chil. </span>2011;<span class="ref-vol">139</span>:505–515.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21879191" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Med+Chil&amp;title=The+role+of+uric+acid+in+heart+failure&amp;author=H+Alca&#x000ed;no&amp;author=D+Greig&amp;author=P+Castro&amp;author=H+Verdejo&amp;author=R+Mellado&amp;volume=139&amp;publication_year=2011&amp;pages=505-515&amp;pmid=21879191&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Hsieh MC, Su HM, Wang SY, Tsai DH, Lin SD, Chen SC. et al. Significant correlation between left ventricular systolic and diastolic dysfunction and decreased glomerular filtration rate. <span><span class="ref-journal">Ren Fail. </span>2011;<span class="ref-vol">33</span>:977–982.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22013930" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ren+Fail&amp;title=Significant+correlation+between+left+ventricular+systolic+and+diastolic+dysfunction+and+decreased+glomerular+filtration+rate&amp;author=MC+Hsieh&amp;author=HM+Su&amp;author=SY+Wang&amp;author=DH+Tsai&amp;author=SD+Lin&amp;volume=33&amp;publication_year=2011&amp;pages=977-982&amp;pmid=22013930&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Amin A, Vakilian F, Maleki M. Serum uric acid levels correlate with filling pressures in systolic heart failure. <span><span class="ref-journal">Congest Heart Fail. </span>2011;<span class="ref-vol">17</span>:80–84.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21449996" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Congest+Heart+Fail&amp;title=Serum+uric+acid+levels+correlate+with+filling+pressures+in+systolic+heart+failure&amp;author=A+Amin&amp;author=F+Vakilian&amp;author=M+Maleki&amp;volume=17&amp;publication_year=2011&amp;pages=80-84&amp;pmid=21449996&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Misra D, Zhu Y, Zhang Y, Choi HK. The independent impact of congestive heart failure status and diuretic use on serum uric acid among men with a high cardiovascular risk profile: a prospective longitudinal study. <span><span class="ref-journal">Semin Arthritis Rheum. </span>2011;<span class="ref-vol">41</span>:471–476.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4228774/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21435695" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Arthritis+Rheum&amp;title=The+independent+impact+of+congestive+heart+failure+status+and+diuretic+use+on+serum+uric+acid+among+men+with+a+high+cardiovascular+risk+profile:+a+prospective+longitudinal+study&amp;author=D+Misra&amp;author=Y+Zhu&amp;author=Y+Zhang&amp;author=HK+Choi&amp;volume=41&amp;publication_year=2011&amp;pages=471-476&amp;pmid=21435695&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE. et al. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. <span><span class="ref-journal">Eur Heart J. </span>2011;<span class="ref-vol">32</span>:712–720.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3056205/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21199831" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Heart+J&amp;title=Hyperuricaemia,+chronic+kidney+disease,+and+outcomes+in+heart+failure:+potential+mechanistic+insights+from+epidemiological+data&amp;author=GS+Filippatos&amp;author=MI+Ahmed&amp;author=JD+Gladden&amp;author=M+Mujib&amp;author=IB+Aban&amp;volume=32&amp;publication_year=2011&amp;pages=712-720&amp;pmid=21199831&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Wu AH, Ghali JK, Neuberg GW, O&#x02019;Connor CM, Carson PE, Levy WC. Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure. <span><span class="ref-journal">Am Heart J. </span>2010;<span class="ref-vol">b160</span>:928–933.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21095282" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Heart+J&amp;title=Uric+acid+level+and+allopurinol+use+as+risk+markers+of+mortality+and+morbidity+in+systolic+heart+failure&amp;author=AH+Wu&amp;author=JK+Ghali&amp;author=GW+Neuberg&amp;author=CM+O&#x02019;Connor&amp;author=PE+Carson&amp;volume=b160&amp;publication_year=2010&amp;pages=928-933&amp;pmid=21095282&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Kim H, Shin HW, Son J, Yoon HJ, Park HS, Cho YK. et al. Uric Acid as prognostic marker in advanced nonischemic dilated cardiomyopathy: comparison with N-terminal pro B-type natriuretic peptide level. <span><span class="ref-journal">Congest Heart Fail. </span>2010;<span class="ref-vol">16</span>:153–158.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20662867" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Congest+Heart+Fail&amp;title=Uric+Acid+as+prognostic+marker+in+advanced+nonischemic+dilated+cardiomyopathy:+comparison+with+N-terminal+pro+B-type+natriuretic+peptide+level&amp;author=H+Kim&amp;author=HW+Shin&amp;author=J+Son&amp;author=HJ+Yoon&amp;author=HS+Park&amp;volume=16&amp;publication_year=2010&amp;pages=153-158&amp;pmid=20662867&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Waring WS, Webb DJ, Maxwell SRJ. Effect of local hyperuricemia on endothelial function in the human forearm vascular bed. <span><span class="ref-journal">Br J Clin Pharmacol. </span>2000;<span class="ref-vol">49</span>:511.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Clin+Pharmacol&amp;title=Effect+of+local+hyperuricemia+on+endothelial+function+in+the+human+forearm+vascular+bed&amp;author=WS+Waring&amp;author=DJ+Webb&amp;author=SRJ+Maxwell&amp;volume=49&amp;publication_year=2000&amp;pages=511&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Trachtenberg BH, Hare JM. Biomarkers of oxidative stress in heart failure. <span><span class="ref-journal">Heart Fail Clin. </span>2009;<span class="ref-vol">5</span>:561–577.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19631180" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Heart+Fail+Clin&amp;title=Biomarkers+of+oxidative+stress+in+heart+failure&amp;author=BH+Trachtenberg&amp;author=JM+Hare&amp;volume=5&amp;publication_year=2009&amp;pages=561-577&amp;pmid=19631180&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Hartupee J, Mann DL. Positioning of Inflammatory Biomarkers in the Heart Failure Landscape. <span><span class="ref-journal">J Cardiovasc Transl Res. </span>2013;<span class="ref-vol">6</span>:485–492.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3811018/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23666808" ref="reftype=pubmed&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cardiovasc+Transl+Res&amp;title=Positioning+of+Inflammatory+Biomarkers+in+the+Heart+Failure+Landscape&amp;author=J+Hartupee&amp;author=DL+Mann&amp;volume=6&amp;publication_year=2013&amp;pages=485-492&amp;pmid=23666808&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=4195965&amp;issue-id=243929&amp;journal-id=2184&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Journal of Cardiovascular and Thoracic Research</span> are provided here courtesy of <strong>Tabriz University of Medical Sciences</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC4195965/pdf/JCVTR-6-153.pdf" class="int-view">PDF (699K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/4195965/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/4195965/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="4195965" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="fvzhfHGp0bJL9KIyTKcL0NzLm67dNte5ljYBfx2hMUUI1vVnTVgcQOsIcGc2wBfw">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F&amp;text=Serum%20Uric%20Acid%20Predicts%20Declining%20of%20Circulating%20Proangiogenic%20Mononuclear%20Progenitor%20Cells%20in%20Chronic%20Heart%20Failure%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4195965%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195965/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/25320662/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/25320662/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC4195965/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/4195965/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC4195965/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
